HSBC Upgrades Gilead Sciences (GILD) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Gilead Sciences (NASDAQ: GILD) | Delayed: 169.16 -1.17 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $170.33 | 52 Week High | $108.63 | |||
| Open | $170.27 | 52 Week Low | $71.39 | |||
| Day High | $172.00 | P/E | 93.46 | |||
| Day Low | $168.44 | EPS | $1.81 | |||
| Volume | 2,058,421 | |||||
